Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)
NCT ID: NCT01294462
Last Updated: 2014-06-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
801 participants
INTERVENTIONAL
2011-02-28
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
NCT02506140
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT02319941
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
NCT01118325
Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
NCT02201667
Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease
NCT02514642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Ticagrelor (AZD6140)
Ticagrelor
90 mg, oral dose twice daily
Acetylsalicylic acid ASA
Low Dose ASA
2
Clopidogrel
Clopidogrel
75 mg, oral dose once daily
Acetylsalicylic acid ASA
Low Dose ASA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ticagrelor
90 mg, oral dose twice daily
Clopidogrel
75 mg, oral dose once daily
Acetylsalicylic acid ASA
Low Dose ASA
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Index event of non-ST or ST segment elevation ACS
Exclusion Criteria
* Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
* Oral anticoagulation therapy that cannot be stopped
* The conditions associated with increased risk of bradycardiac events
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Judith Hsia, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Ichinomiya-shi, Aichi-ken, Japan
Research Site
Nagoya, Aichi-ken, Japan
Research Site
Okazaki-shi, Aichi-ken, Japan
Research Site
Toyohashi, Aichi-ken, Japan
Research Site
Toyota-shi, Aichi-ken, Japan
Research Site
Akita, Akita, Japan
Research Site
Ichihara-shi, Chiba, Japan
Research Site
Kamogawa-shi, Chiba, Japan
Research Site
Kisarazu-shi, Chiba, Japan
Research Site
Matsuyama, Ehime, Japan
Research Site
Fukui-shi, Fukui, Japan
Research Site
Fukuoka, Fukuoka, Japan
Research Site
Kasuya-gun, Fukuoka, Japan
Research Site
Kurume, Fukuoka, Japan
Research Site
Gifu, Gifu, Japan
Research Site
Isesaki, Gunma, Japan
Research Site
Maebashi, Gunma, Japan
Research Site
Takasaki-shi, Gunma, Japan
Research Site
Kure, Hiroshima, Japan
Research Site
Sapporo, Hokkaido, Japan
Research Site
Akashi-shi, Hyōgo, Japan
Research Site
Amagasaki-shi, Hyōgo, Japan
Research Site
Kawanishi-shi, Hyōgo, Japan
Research Site
Kobe, Hyōgo, Japan
Research Site
Nishinomiya, Hyōgo, Japan
Research Site
Takarazuka-shi, Hyōgo, Japan
Research Site
Higashiibaragi-gun, Ibaragi, Japan
Research Site
Sashima-gun, Ibaragi, Japan
Research Site
Hakusan-shi, Ishikawa-ken, Japan
Research Site
Kanazawa, Ishikawa-ken, Japan
Research Site
Sakaide-shi, Kagawa-ken, Japan
Research Site
Atsugi-shi, Kanagawa, Japan
Research Site
Isehara, Kanagawa, Japan
Research Site
Kamakura-shi, Kanagawa, Japan
Research Site
Kawasaki-shi, Kanagawa, Japan
Research Site
Sagamihara-shi, Kanagawa, Japan
Research Site
Yamato-shi, Kanagawa, Japan
Research Site
Yokohama, Kanagawa, Japan
Research Site
Nankoku-shi, Kochi, Japan
Research Site
Kumamoto, Kumamoto, Japan
Research Site
Yatsushiro, Kumamoto, Japan
Research Site
Kyoto, Kyoto, Japan
Research Site
Sendai, Miyagi, Japan
Research Site
Azumino-shi, Nagano, Japan
Research Site
Ueda-shi, Nagano, Japan
Research Site
Nagasaki, Nagasaki, Japan
Research Site
Ōita, Oita Prefecture, Japan
Research Site
Kurashiki, Okayama-ken, Japan
Research Site
Okayama, Okayama-ken, Japan
Research Site
Hirakata, Osaka, Japan
Research Site
Kawachinagano-shi, Osaka, Japan
Research Site
Osaka, Osaka, Japan
Research Site
Sakai-shi, Osaka, Japan
Research Site
Saga, Saga-ken, Japan
Research Site
Ageo-shi, Saitama, Japan
Research Site
Hidaka, Saitama, Japan
Research Site
Sayama-shi, Saitama, Japan
Research Site
Kusatsu-shi, Shiga, Japan
Research Site
Moriyama, Shiga, Japan
Research Site
Matsue, Shimane, Japan
Research Site
Hamamatsu, Shizuoka, Japan
Research Site
Izunokuni, Shizuoka, Japan
Research Site
Shimada-shi, Shizuoka, Japan
Research Site
Sunto-gun, Shizuoka, Japan
Research Site
Komatsushima-shi, Tokushima, Japan
Research Site
Tokushima, Tokushima, Japan
Research Site
Adachi-ku, Tokyo, Japan
Research Site
Bunkyo-ku, Tokyo, Japan
Research Site
Bunkyo, Tokyo, Japan
Research Site
Chiyoda-ku, Tokyo, Japan
Research Site
Itabashi-ku, Tokyo, Japan
Research Site
Meguro City, Tokyo, Japan
Research Site
Ome-shi, Tokyo, Japan
Research Site
Shinagawa-ku, Tokyo, Japan
Research Site
Shinjuku, Tokyo, Japan
Research Site
Suginami-ku, Tokyo, Japan
Research Site
Tanabe-shi, Wakayama, Japan
Research Site
Wakayama, Wakayama, Japan
Research Site
Chuo-shi, Yamanashi, Japan
Research Site
Cheonan, Chungcheongnam-do, South Korea
Research Site
Daejeon, , South Korea
Research Site
Incheon, , South Korea
Research Site
Seoul, , South Korea
Research Site
Niao-song-shiang, Kaohsiung, Taiwan
Research Site
Kweishan Shiang, Taoyuan Hsien, Taiwan
Research Site
Taichung, , Taiwan
Research Site
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D5130C00027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.